Dipyridamole
Dipyridamole is a pharmaceutical drug with 25 clinical trials. Historical success rate of 95.0%.
Success Metrics
Based on 19 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
7
Mid Stage
13
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
95.0%
19 of 20 finished
5.0%
1 ended early
0
trials recruiting
25
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy(ESAWAAPT)
Registry of IgA Nephropathy in Chinese Children
Apixaban After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation
Clinical Trial of Dipyridamole in Schizophrenia
Dipyridamole for Immune Activation in HIV
Clinical Trials (25)
Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy(ESAWAAPT)
Registry of IgA Nephropathy in Chinese Children
Apixaban After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation
Clinical Trial of Dipyridamole in Schizophrenia
Dipyridamole for Immune Activation in HIV
Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection
Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy
Persantine: Variation in Response Trial
Efficacy of Allopurinol and Dypiridamole in Acute Mania
Assessment of the Efficacy of Ocular Dipyridamole in the Treatment of Dry Eye Symptomology in Subjects With Pterygium
Persantin Preceding Elective PCI
Pharmacokinetics of Dipyridamole Administered as Aggrenox® (Dipyridamole Extended Release Plus Aspirin) Capsule Versus Dipyridamole Immediate Release Plus Aspirin Following Alteration of Stomach pH
A Phase II Trial Comparing Z-102 With Placebo In Patients With Moderate To Severe Rheumatoid Arthritis
Multicenter Study to Evaluate CRx-102 vs. Each of Its Components to Treat Active Rheumatoid Arthritis
Recurrent Carotid Stenosis
Platelet Drug Trial in Coronary Disease Progression
Platelet-Inhibitor Drug Trial in Coronary Angioplasty
Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer
Can Dipyridamole Induce Protection Against Ischemia and Reperfusion Injury in Patients Undergoing Elective Coronary Artery Bypass Grafting (CABG)?
S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 25